Mindscape Collective is now The Consciousness Library. Same library, new name. You may need to sign in again. About the change
Skip to content

Peter J. Thomas

2 papers in the library · 337 citations · publishing 1994-2002

Papers

What Geometric Visual Hallucinations Tell Us about the Visual Cortex

Neural Computation March 1, 2002 Paul C. Bressloff, Jack D. Cowan, Martin Golubitsky et al. 292 citations

Geometric visual hallucinations—tunnels, spirals, lattices, and cobwebs—are seen under psychedelics, flickering lights, or during sleep transitions. These patterns appear in both eyes and move with them, indicating a brain origin. A theory explains them as arising in the primary visual cortex (V1), modeled as a lattice of interconnected hypercolumns. The lateral connections between hypercolumns are assumed to have symmetries under the Euclidean group E(2). When V1's uniform resting state becomes unstable, spontaneous activity patterns emerge that, when mapped back to the visual field, correspond to the hallucination forms. The results depend on the connectivity details and suggest that the same cortical mechanisms process edges, contours, surfaces, and textures.

Immunological Consequences of In Vitro Exposure to Lysergic Acid Diethylamide (LSD)

Immunopharmacology and Immunotoxicology January 1, 1994 Robert V. House, Peter J. Thomas, Hemendra N. Bhargava 45 citations

Lysergic acid diethylamide (LSD) directly alters immune function when immune cells are exposed to it in a laboratory setting. At a high concentration of 100 microM, LSD suppresses the proliferation of B-lymphocytes, reduces production of the cytokines IL-2, IL-4, and IL-6, and inhibits the induction of cytotoxic T-lymphocytes. In contrast, at lower concentrations between 0.0001 and 0.1 microM, LSD enhances both basal and IL-2-augmented natural killer (NK) cell activity. These differential effects suggest that LSD can directly influence components of the immune system at concentrations potentially reached in the human body.